| Product Code: ETC8531189 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Age-Related Macular Degeneration Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Age-Related Macular Degeneration Market - Industry Life Cycle |
3.4 Netherlands Age-Related Macular Degeneration Market - Porter's Five Forces |
3.5 Netherlands Age-Related Macular Degeneration Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Netherlands Age-Related Macular Degeneration Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Netherlands Age-Related Macular Degeneration Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Age-Related Macular Degeneration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the Netherlands |
4.2.2 Technological advancements in treatment options for age-related macular degeneration |
4.2.3 Growing awareness about eye health and regular check-ups |
4.3 Market Restraints |
4.3.1 High treatment costs for age-related macular degeneration |
4.3.2 Limited access to specialized healthcare services in certain regions of the Netherlands |
4.3.3 Stringent regulatory requirements for approval of new treatments |
5 Netherlands Age-Related Macular Degeneration Market Trends |
6 Netherlands Age-Related Macular Degeneration Market, By Types |
6.1 Netherlands Age-Related Macular Degeneration Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Eylea, 2021- 2031F |
6.1.4 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Lucentis, 2021- 2031F |
6.1.5 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Beovu, 2021- 2031F |
6.1.6 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Age-Related Macular Degeneration Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Dry AMD, 2021- 2031F |
6.2.3 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Wet AMD, 2021- 2031F |
6.3 Netherlands Age-Related Macular Degeneration Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.3.4 Netherlands Age-Related Macular Degeneration Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Netherlands Age-Related Macular Degeneration Market Import-Export Trade Statistics |
7.1 Netherlands Age-Related Macular Degeneration Market Export to Major Countries |
7.2 Netherlands Age-Related Macular Degeneration Market Imports from Major Countries |
8 Netherlands Age-Related Macular Degeneration Market Key Performance Indicators |
8.1 Average wait time for patients to receive treatment |
8.2 Number of healthcare facilities offering specialized care for age-related macular degeneration |
8.3 Percentage of population undergoing regular eye screenings |
9 Netherlands Age-Related Macular Degeneration Market - Opportunity Assessment |
9.1 Netherlands Age-Related Macular Degeneration Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Netherlands Age-Related Macular Degeneration Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Netherlands Age-Related Macular Degeneration Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Age-Related Macular Degeneration Market - Competitive Landscape |
10.1 Netherlands Age-Related Macular Degeneration Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Age-Related Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here